Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Anybody know the facts per this -emit

RE: Anybody know the facts per this -emit

posted on Jun 12, 2006 06:03PM
Not sure what you are asking here, however, IMO the share buy back is directed towards the ourstanding share only...not warrents or options. I was looking at the point that Swartz, for instance, already has about close to the 10% of the outstanding right now. If we buy back shares directly form the market, then there count could go over 10% and there is an agreement with them that states this will not happen. So, IMO , PTSC would have to buy the shares directly from them. This would not help the trading price of the stock, by holding up the price at the bid during the buy back. But less float is a very good plus, if S and L have more warrents or options, then when the sell the stock, they could still end up with more...LOL. but not over 10% at any time.

Hope that answers you question.

Share
New Message
Please login to post a reply